• Je něco špatně v tomto záznamu ?

Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer

M Koleckova, J Ehrmann, J Bouchal, M Janikova, A Brisudova, J Srovnal, K Staffova, M Svoboda, O Slaby, L Radova, K Vomackova, B Melichar, L Veverkova, Z Kolar

. 2021 ; 11 (1) : 5145.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc22008184

Grantová podpora
NV16-31997A MZ0 CEP - Centrální evidence projektů

Triple negative breast cancers (TNBC) are a morphologically and genetically heterogeneous group of breast cancers with uncertain prediction of biological behavior and response to therapy. Epithelial to mesenchymal transition (EMT) is a dynamic process characterized by loss of typical epithelial phenotype and acquisition of mesenchymal characteristics. Aberrant activation of EMT can aggravate the prognosis of patients with cancer, however, the mechanisms of EMT and role of microRNAs (miRNAs) in EMT activation is still unclear. The aim of our study was to analyze miRNA expression within areas of TNBCs with cellular morphology that may be related to the EMT process and discuss possible associations. Out of all 3953 re-examined breast cancers, 460 breast cancers were diagnosed as TNBC (11.64%). With regard to complete tumor morphology preservation, the tissue samples obtained from core-cut biopsies and influenced by previous neoadjuvant therapy were excluded. We assembled a set of selected 25 cases to determine miRNA expression levels in relation to present focal spindle cell and apocrine cell morphology within individual TNBCs. We used descriptive (histological typing and morphology), morphometric, molecular (microdissection of tumor and non-tumor morphologies, RNA isolation and purification, microchip analysis) and bioinformatic analysis (including pathway analysis). The results were verified by quantitative real-time PCR (RT-qPCR) on an extended set of 70 TNBCs. The majority of TNBCs were represented by high-grade invasive carcinomas of no special type (NST) with medullary features characterized by well-circumscribed tumors with central necrosis or fibrosis and frequent tendency to spindle-cell and/or apocrine cell transformation. Apocrine and spindle cell transformation showed a specific miRNA expression profile in comparison to other tumor parts, in situ carcinoma or non-tumor structures, particularly down-regulated expression of hsa-miRNA-143-3p and hsa-miRNA-205-5p and up-regulated expression of hsa-miR-22-3p, hsa-miRNA-185-5p, and hsa-miR-4443. Apocrine cell tumor morphology further revealed decreased expression of hsa-miR-145-5p and increased expression of additional 14 miRNAs (e.g. hsa-miR-182-5p, hsa-miR-3135b and hsa-miR-4417). Pathway analysis for target genes of these miRNAs revealed several shared biological processes (i.e. Wnt signaling, ErbB signaling, MAPK signaling, endocytosis and axon guidance), which may in part contribute to the EMT and tumor progression. We provide the first miRNA expression profiling of specific tissue morphologies in TNBC. Our results demonstrate a specific miRNA expression profile of apocrine and spindle cell morphology which can exhibit a certain similarity with the EMT process and may also be relevant for prognosis and therapy resistance of TNBC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22008184
003      
CZ-PrNML
005      
20220404150508.0
007      
ta
008      
220315s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-021-84350-2 $2 doi
035    __
$a (PubMed)33664322
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kolečková, Markéta, $d 1990- $7 xx0238146 $u Koleckova, Marketa. Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic.
245    10
$a Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer / $c M Koleckova, J Ehrmann, J Bouchal, M Janikova, A Brisudova, J Srovnal, K Staffova, M Svoboda, O Slaby, L Radova, K Vomackova, B Melichar, L Veverkova, Z Kolar
520    9_
$a Triple negative breast cancers (TNBC) are a morphologically and genetically heterogeneous group of breast cancers with uncertain prediction of biological behavior and response to therapy. Epithelial to mesenchymal transition (EMT) is a dynamic process characterized by loss of typical epithelial phenotype and acquisition of mesenchymal characteristics. Aberrant activation of EMT can aggravate the prognosis of patients with cancer, however, the mechanisms of EMT and role of microRNAs (miRNAs) in EMT activation is still unclear. The aim of our study was to analyze miRNA expression within areas of TNBCs with cellular morphology that may be related to the EMT process and discuss possible associations. Out of all 3953 re-examined breast cancers, 460 breast cancers were diagnosed as TNBC (11.64%). With regard to complete tumor morphology preservation, the tissue samples obtained from core-cut biopsies and influenced by previous neoadjuvant therapy were excluded. We assembled a set of selected 25 cases to determine miRNA expression levels in relation to present focal spindle cell and apocrine cell morphology within individual TNBCs. We used descriptive (histological typing and morphology), morphometric, molecular (microdissection of tumor and non-tumor morphologies, RNA isolation and purification, microchip analysis) and bioinformatic analysis (including pathway analysis). The results were verified by quantitative real-time PCR (RT-qPCR) on an extended set of 70 TNBCs. The majority of TNBCs were represented by high-grade invasive carcinomas of no special type (NST) with medullary features characterized by well-circumscribed tumors with central necrosis or fibrosis and frequent tendency to spindle-cell and/or apocrine cell transformation. Apocrine and spindle cell transformation showed a specific miRNA expression profile in comparison to other tumor parts, in situ carcinoma or non-tumor structures, particularly down-regulated expression of hsa-miRNA-143-3p and hsa-miRNA-205-5p and up-regulated expression of hsa-miR-22-3p, hsa-miRNA-185-5p, and hsa-miR-4443. Apocrine cell tumor morphology further revealed decreased expression of hsa-miR-145-5p and increased expression of additional 14 miRNAs (e.g. hsa-miR-182-5p, hsa-miR-3135b and hsa-miR-4417). Pathway analysis for target genes of these miRNAs revealed several shared biological processes (i.e. Wnt signaling, ErbB signaling, MAPK signaling, endocytosis and axon guidance), which may in part contribute to the EMT and tumor progression. We provide the first miRNA expression profiling of specific tissue morphologies in TNBC. Our results demonstrate a specific miRNA expression profile of apocrine and spindle cell morphology which can exhibit a certain similarity with the EMT process and may also be relevant for prognosis and therapy resistance of TNBC.
650    07
$a dospělí $7 D000328 $2 czmesh
650    07
$a senioři $7 D000368 $2 czmesh
650    07
$a senioři nad 80 let $7 D000369 $2 czmesh
650    17
$a apokrinní žlázy $x mikrobiologie $x patologie $7 D001050 $2 czmesh
650    17
$a epitelo-mezenchymální tranzice $x genetika $7 D058750 $2 czmesh
650    07
$a ženské pohlaví $7 D005260 $2 czmesh
650    07
$a stanovení celkové genové exprese $7 D020869 $2 czmesh
650    07
$a regulace genové exprese u nádorů $x genetika $7 D015972 $2 czmesh
650    07
$a lidé $7 D006801 $2 czmesh
650    17
$a mikro RNA $x genetika $7 D035683 $2 czmesh
650    07
$a lidé středního věku $7 D008875 $2 czmesh
650    17
$a triple-negativní karcinom prsu $x genetika $x patologie $7 D064726 $2 czmesh
650    07
$a signální dráha Wnt $x genetika $7 D060449 $2 czmesh
700    1_
$a Ehrmann, Jiří, $d 1967- $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic $7 jo2003163162
700    1_
$a Bouchal, Jan, $d 1973- $7 xx0034399 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
700    1_
$a Janíková, Mária $7 xx0267892 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
700    1_
$a Brisudová, Aneta $7 xx026017701 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
700    1_
$a Srovnal, Josef $7 xx0091239 $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
700    1_
$a Staffová, Kateřina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
700    1_
$a Svoboda, Marek, $d 1975- $7 xx0098478 $u Central European Institute of Technology, Masaryk University, 625 00, Brno, Czech Republic
700    1_
$a Slabý, Ondřej, $d 1981- $7 js20030220015 $u Central European Institute of Technology, Masaryk University, 625 00, Brno, Czech Republic
700    1_
$a Radová, Lenka $7 xx0092752 $u Central European Institute of Technology, Masaryk University, 625 00, Brno, Czech Republic
700    1_
$a Vomáčková, Katherine $7 xx0142837 $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
700    1_
$a Melichar, Bohuslav, $d 1965- $7 skuk0000853 $u Department of Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
700    1_
$a Veverková, Lucie $7 xx0238149 $u Department of Radiology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
700    1_
$a Kolář, Zdeněk, $d 1953- $7 jn20000710256 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital, 775 15, Olomouc, Czech Republic
773    0_
$t Scientific Reports $g Roč. 11, č. 1 (2021), s. 5145 $p Sci. rep. $x 2045-2322 $w MED00182195
773    0_
$p Sci. rep. $g 11(1):5145, 2021 03 04
910    __
$a ABA008 $y p $z 0
990    __
$a 20220315151054 $b ABA008
991    __
$a 20220404150506 $b ABA008
999    __
$a ok $b bmc $g 1770222 $s 1159378
BAS    __
$a 3
BMC    __
$a 2021 $b 11 $c 1 $d 5145 $x MED00182195 $i 2045-2322 $m Scientific reports
GRA    __
$a NV16-31997A $p MZ0
LZP    __
$a 2021-granty

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace